Investment analysts at William Blair initiated coverage on shares of Quintiles Transnational Holdings (NYSE: Q) in a note issued to investors on Monday, AnalystRatings.Net reports. The firm set an “outperform” rating on the stock.
A number of other firms have also recently commented on Q. Analysts at Citigroup Inc. reiterated a “neutral” rating on shares of Quintiles Transnational Holdings in a research note to investors on Wednesday, June 19th. Separately, analysts at Barclays Capital reiterated an “overweight” rating on shares of Quintiles Transnational Holdings in a research note to investors on Tuesday, June 18th. They now have a $51.00 price target on the stock. Finally, analysts at Raymond James initiated coverage on shares of Quintiles Transnational Holdings in a research note to investors on Tuesday, June 18th. They set an “outperform” rating and a $50.00 price target on the stock.
One research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $46.79.
Shares of Quintiles Transnational Holdings (NYSE: Q) traded down 1.50% during mid-day trading on Monday, hitting $42.995. Quintiles Transnational Holdings has a one year low of $41.50 and a one year high of $46.50. The stock’s 50-day moving average is currently $43.47. The company has a market cap of $4.979 billion and a P/E ratio of 28.16.
Quintiles Transnational Holdings Inc is a provider of biopharmaceutical development services and commercial outsourcing services.